CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | FOEHR MATTHEW W Director | Grant or award | +3,150 | 135,186 | ||
| 2026-01-02 | FOEHR MATTHEW W Director | Option exercise · Stock Option (Right to Buy) | −16,000 | 0 | ||
| 2026-01-02 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-01-02 | Rouan Sarah Kathryn Director | Grant or award | +3,150 | 4,390 | ||
| 2026-01-02 | Rouan Sarah Kathryn Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2025-10-28 | Mancini Marianna Chief Operating Officer | Sale | −6,185 | $35.00 | $216K | 382,467 |
| 2025-10-28 | Lian Brian President & CEO | Sale | −38,989 | $35.01 | $1.4M | 2,419,109 |
| 2025-10-28 | ZANTE GREG Chief Financial Officer | Sale | −6,185 | $35.00 | $216K | 173,592 |
| 2025-10-27 | Mancini Marianna Chief Operating Officer | Grant or award | +11,117 | 388,652 | ||
| 2025-10-27 | Rowland Charles A Jr Director | Grant or award | +16,000 | $4.48 | $72K | 46,000 |
| 2025-10-27 | Rowland Charles A Jr Director | Grant or award | +22,000 | $5.80 | $128K | 68,000 |
| 2025-10-27 | Rowland Charles A Jr Director | Grant or award | +22,000 | $4.88 | $107K | 90,000 |
| 2025-10-27 | Rowland Charles A Jr Director | Sale | −60,000 | $35.57 | $2.1M | 30,000 |
| 2025-10-27 | Rowland Charles A Jr Director | Option exercise · Stock Option (Right to Buy) | −16,000 | 0 | ||
| 2025-10-27 | Rowland Charles A Jr Director | Option exercise · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-10-27 | Rowland Charles A Jr Director | Option exercise · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-10-27 | Lian Brian President & CEO | Grant or award | +70,084 | 2,458,098 | ||
| 2025-10-27 | ZANTE GREG Chief Financial Officer | Grant or award | +11,117 | 179,777 | ||
| 2025-07-03 | Lian Brian President & CEO | Sale | −26,889 | $27.80 | $748K | 2,388,014 |
| 2025-07-03 | ZANTE GREG Chief Financial Officer | Sale | −4,266 | $27.76 | $118K | 168,660 |
Page 3 of 27 · 528 trades